Family Sues Trulieve Over Death in Massachusetts Cannabis Facility

The lawsuit alleges the company and contractors hired by it did not do enough to ensure a safe working environment.

The family of Lorna McMurrey, a 27-year-old woman who died from an asthma attack at a Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) production facility in Massachusetts, has filed a wrongful death lawsuit against the company.

McMurrey, who was employed at the Holyoke facility, died in early 2022 after being exposed to ground cannabis dust and mold in the facility’s pre-roll joint production room.

The lawsuit, filed in Hampden County Superior Court, alleges that Trulieve, along with its environmental health and safety manager and the contractors responsible for the facility’s HVAC system, failed to implement adequate safety measures to protect workers from airborne hazards.

According MassLive, Jeremy M. Carroll, the lawyer representing McMurrey’s family, said that the named parties “failed to develop and implement appropriate safety (policies) across its facilities throughout the United States, including its Holyoke facility. Had they done so, Lorna McMurrey would be alive today.”

McMurrey’s death was detailed in a federal report last week, which was conducted alongside the Massachusetts Department of Public Health and linked McMurrey’s death to the facility’s failure to control grated cannabis as a possible respiratory hazard. Despite previous claims by Trulieve defending its facility management and air filtration systems, the lawsuit contends that these measures were insufficient.

The federal report also highlighted “occupational allergic diseases” as an emerging concern in the wider U.S. cannabis industry. The Centers for Disease Control and Prevention found that respiratory and skin symptoms were reported by several of McMurrey’s coworkers.

“Evaluation of workers with new-onset or worsening asthma is essential, along with prompt diagnosis and medical management,” the report stated, adding that McMurrey’s death was “consistent with fatal asthma triggered by cannabis allergy.”

The report and lawsuit come at a time when the cannabis industry is under rising scrutiny for its workplace safety standards. Poor safety oversight also spurred the abrupt shuttering of Curaleaf’s (OTCQX: CURLF) Bellmawr, New Jersey, production facility earlier this year, former workers close to the situation told Green Market Report.

The state’s health department, in response to McMurrey’s death, also released a bulletin urging healthcare providers to be vigilant in identifying work-related asthma among cannabis business employees and offered tips for preventing similar tragedies.

“The legalized cannabis industry in Massachusetts is relatively new and the impact on the health and safety of workers demands our careful attention,” Massachusetts Public Health Commissioner Robert Goldstein wrote.

Trulieve, in response to McMurrey’s death, paid a nearly $15,000 settlement to the Occupational Safety and Health Administration and announced the shutdown of its Massachusetts operations. The company’s response, however, has done little to mitigate concerns about the industry-wide implications of such incidents.

In July, another death of a worker occurred at an Illinois-based facility operated by Green Thumb Industries (CSE: GTII) (OTCQX: GTBIF). Julie Devinney, 60, tragically collapsed and was found “gasping” to breathe.

Adam Jackson

Adam Jackson writes about the cannabis industry for the Green Market Report. He previously covered the Missouri Statehouse for the Columbia Missourian and has written for the Missouri Independent. He most recently covered retail, restaurants and other consumer companies for Bloomberg Business News. You can find him on Twitter at @adam_sjackson and email him at adam.jackson@crain.com.


2 comments

  • michael g mclaughlin

    November 21, 2023 at 5:50 pm

    I am sorry for the death, but cannabis facilities cannot be sterile environments. People with asthma should not be allowed to work there.

    Reply

    • Sarah H

      November 21, 2023 at 7:19 pm

      They don’t need to be sterile. These companies need to take accountability for the safety of their workers. Asthma can be dealt with in these facilities with proper ventilation and PPE.

      Reply

Leave a Reply

Your email address will not be published. Required fields are marked *

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.

 Sign up


About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

Get the latest cannabis news delivered right to your inbox

The Morning Rise

Unpack the industry with the daily cannabis newsletter for business leaders.